Democratic Sen. Elizabeth Warren (MA) and Senator-elect and Peter Welch (VT) (Michael Brochstein/Sipa USA via AP images)

Pfiz­er's plan for $110+ Covid-19 vac­cines riles up US sen­a­tors

Pfiz­er’s Covid-19 vac­cine be­came the best-sell­ing med­ical prod­uct of all time in 2021, haul­ing in al­most $37 bil­lion in just one year.

But as the Big Phar­ma has seen sales de­cline with the chang­ing of the vari­ants and new gov­ern­ment funds run­ning dry, the firm’s mR­NA vac­cine will have to switch over to the com­mer­cial mar­ket at some point soon, and be cov­ered by in­sur­ance. Two key sen­a­tors are tak­ing is­sue with that switch, which comes at a much steep­er price — at least $110 per jab, rather than $19.50 per dose at the be­gin­ning of the pan­dem­ic.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.